Isomorphic Labs
Rob Gillespie is a seasoned professional in medicinal chemistry and drug design, currently serving as Senior Research Investigator in Medicinal Drug Design at Isomorphic Labs since December 2024. Prior experience includes a Senior Scientist role at Nxera Pharma, where leadership was provided to a team of 24 external chemists on key projects. Rob's academic background includes a Ph.D. in Organic Chemistry from ETH Zurich and significant research contributions at the Institute of Cancer Research focused on paediatric brain tumours. Additional expertise is demonstrated through positions at Roche, Vertex Pharmaceuticals, and Georg Thieme Verlag, as well as a solid foundation in chemistry from the University of York.
This person is not in any teams
Isomorphic Labs
7 followers
Isomorphic Labs is a new Alphabet company and commercial venture which aims to reimagine the entire drug discovery process from first principles with an AI-first approach, and, ultimately, to model and understand some of the fundamental mechanisms of life. Using computational advances, we’re working at the cutting edge in the new era of ‘digital biology’. By significantly increasing the pace of scientific research and efficacy of new medicines, we will be at the forefront of breakthroughs that will benefit millions of people.